CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
They filed their motions with the FTC's in-house court and shared it with Reuters. The companies said Khan, along with Slaughter and Bedoya, displayed bias against pharmacy benefit managers and prejudged their pricing models.